Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
Clinical trial NCT03740191 · TERMINATED
Trial details
- NCT number
- NCT03740191
- Sponsor
- EBG MedAustron GmbH
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-03
- Primary completion
- 2025-03-14
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.